BRANDY CHAMBERS: Open Payments
NPI 1609444108 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 36 payments from 18 companies in 2025. Trend: 2023 $555 · 2024 $752 · 2025 $708
Food & beverage: $648Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $142 |
| PFIZER INC. | 4 | $68 |
| Astellas Pharma US Inc | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Bausch Health US, LLC | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $32 |
| BIOTRONIK NRO, Inc. | 1 | $22 |
Products named: VRAYLAR, NURTEC ODT, REXULTI, TRINTELLIX, Auvelity, FANAPT, APLENZIN, Prospera.
Industry payments across GA — which companies pay providers there.
